 The first and only modafinil products was approved in November 2017, but its marketing status in mainland China is still unknown.In Japan, modafinil is Schedule I psychotropic drug.Cephalon has licensed Alfresa Corporation to produce, and Mitsubishi Tanabe Pharma to sell modafinil products under the trade name Modiodal in Japan.